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Abstract
To assess the eVect of NT-4 deprivation on maturation of retinal circuitry, we investigated a mouse with targeted deletion of the gene
encoding nt-4 (nt-4¡/¡). In particular, we studied neurons immunostained by an antibody recognizing tyrosine hydroxylase (TH), the rate
limiting enzyme for dopamine (DA) synthesis. We found that TH immunopositive processes were altered in the retina of nt-4¡/¡. Alteration
of TH immunopositive processes in nt-4¡/¡ mice resulted in changes of DA turnover, as assessed by high-pressure liquid chromatography
measurements. These Wndings suggest that retinal NT-4 plays a role in the morphological maturation of dopaminergic retinal cells.
© 2007 Elsevier Ltd. All rights reserved.
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The expression of neurotrophins has been studied
extensively in the central nervous system (CNS), includ-
ing the visual system (von Bartheld, 1998). BDNF and
NT-4 are two neurotrophins expressed in several areas of
the CNS that bind to the same TrkB receptor (Barbacid,
1994). The TrkB receptor is expressed by distinct classes
of retinal cells (Cellerino & Kohler, 1997; Di Polo,
Cheng, Bray, & Aguayo, 2000; Jelsma, Friedman, Berke-
laar, Bray, & Aguayo, 1993) and its signalling modulates
the retinal response to light (Rohrer, Korenbrot, LaVail,
Reichardt, & Xu, 1999; Rohrer, LaVail, Jones, & Reic-
hardt, 2001).
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doi:10.1016/j.visres.2007.01.017BDNF mRNA and protein are expressed by several sub-
types of retinal cells and their expression is activity-depen-
dent (Bennett, Zeiler, & Jones, 1999; Chytrova & Johnson,
2004; Hallbook, Backstrom, Kullander, Ebendal, & Carri,
1996; Herzog, Bailey, & Barde, 1994; Herzog & von Bart-
held, 1998; Karlsson & Hallbook, 1998; Perez & Caminos,
1995; Pollock & Frost, 2003; Seki, Nawa, Fukuchi, Abe, &
Takei, 2003). BDNF is required for retinal ganglion cell
development and function (Alsina, Vu, & Cohen-Cory,
2001; Cellerino, Carroll, Thoenen, & Barde, 1997; Celle-
rino, Pinzon-Duarte, Carroll, & Kohler, 1998; Cohen-Cory
& Fraser, 1995; Du & Poo, 2004; Isenmann, Cellerino,
Gravel, & Bahr, 1999; Lom, Cogen, Sanchez, Vu, & Cohen-
Cory, 2002; Menna, Cenni, Naska, & MaVei, 2003; Pollock
et al., 2003; Rothe, Bahring, Carroll, & Grantyn, 1999), for
phenotypic speciWcation of amacrine cells (Cellerino,
Arango-Gonzalez, Pinzon-Duarte, & Kohler, 2003; Rick-
man, 2000), horizontal cells (Pinzon-Duarte, Arango-
Gonzalez, Guenther, & Kohler, 2004), bipolar cells
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1998), and Müller glial cells (Pinzon-Duarte et al., 2004;
Wahlin, Campochiaro, Zack, & Adler, 2000).
Dopaminergic amacrine cells are a well-described target
of BDNF in the retina. They express TrkB receptors (Celle-
rino & Kohler, 1997) and are aVected in BDNF-deWcient
mice (Cellerino et al., 1998). Moreover, dopamine release is
stimulated by BDNF (Neal, Cunningham, Lever, Pezet, &
Malcangio, 2003) and BDNF protects dopaminergic ama-
crine cells in vivo (Seki et al., 2004).
The other TrkB-ligand, NT-4 (Berkemeier et al., 1991;
Hallbook, Ibanez, & Persson, 1991), is expressed at low
levels in several brain areas (Timmusk, Belluardo, Metsis, &
Persson, 1993). SpeciWc and restricted deWcits were detected
in the CNS of mice with a targeted deletion of nt-4 gene
(nt-4¡/¡) (Xie et al., 2000; Roosen et al., 2001; Smith, Leil, &
Liu, 2003) demonstrating that low levels of NT-4 have
physiological relevance.
Despite the well-known pharmacological eVect of exoge-
nous NT-4 upon retinal cells (Cohen, Bray, & Aguayo,
1994; Cui & Harvey, 1994, 1995; Cui & Harvey, 2000;
Sawai, Clarke, Kittlerova, Bray, & Aguayo, 1996; Spalding,
Cui, & Harvey, 1998; Spalding, Cui, & Harvey, 2005), the
role of endogenous NT-4 is still unknown. In addition,
evidence that NT-4 is expressed in mammalian retina is
lacking.
In the present paper, we investigated whether NT-4
mRNA is expressed in the mouse retina, using RT-PCR
and in situ hybridization. To assess the eVects of NT-4
deprivation on retinal circuitry we analysed a line of
null mutant mice with nt-4 gene deletion (nt-4¡/¡). In
particular, we focused on the eVects of NT-4 deprivation
on tyrosine hydroxylase (TH) immunostained retinal
cells, which synthesize and release dopamine (for a review
see Witkovsky, 2004), express TrkB (Cellerino & Kohler,
1997), and are responsive to BDNF (Cellerino et al.,
1998). Potential eVects of NT-4 depletion on dopamine
retinal content were evaluated by high-pressure liquid
chromatography (HPLC). We found that NT-4 is
expressed both in developing and adult retina. Its absence
induces speciWc changes in dopaminergic retinal cell
morphology and in retinal dopamine turnover.
2. Methods
NT-4 knock out mice (nt-4¡/¡; 129S4/SvJae-Ntf5tm1Jae strain, Liu,
Ernfors, Wu, & Jaenisch, 1995) were obtained from the Jackson Laborato-
ries (Bar Harbor, Maine). Mice with a null mutation of the NT-4 gene are
pigmented, viable and fertile and were maintained as a pure homozygous
strain. The corresponding 129/Sv strain (Jackson Laboratories, catalog)
was used as a wild type control (Fox et al., 2001; Roosen et al., 2001; Smith
et al., 2003; Stucky, Shin, & Lewin, 2002; Xie et al., 2000). Animals were
kept in a 12 h light/12 h dark cycle, with the illumination level below 60
photopic lux; lights were on from zeitgeber time (ZT) 0-12 and oV from ZT
12-24. Mice were genotyped by PCR using genomic DNA isolated from
tail biopsies to conWrm homozygosity for nt-4 wild type (WT) and knock
out (KO) mice.
Experiments were done in compliance with the Italian laws for the use
of animals in research. For euthanasia, adult (2 months) and young mice(postnatal day 15, P15) were anesthetized with an intraperitoneal injection
of avertin (1.2% tribromoethanol and 2.4% amylene hydrate in distilled
water, 0.1 ml/5 g body weight).
2.1. Retinal RNA extraction and RT-PCR
NT-4 WT (nt-4+/+, adult mice n D 4, P15 mice n D 4) mice were anesthe-
tized with avertin, the eyes enucleated, and the retinas isolated. Total RNA
from retina was extracted using TriZol (Gibco BRL, Carlsbad, CA).
DNase 1 treatment (DNA-free from Ambion Inc, Austin, TX) was carried
out according to supplier’s instructions to eliminate genomic DNA. Total
RNA (5 g) was used for Wrst strand cDNA synthesis using SUPER-
SCRIPT reverse transcriptase (Life Technologies Inc, Carlsbad, CA). The
cDNA was ampliWed in a total volume of 50 l with 1.5 mM MgCl2,
0.2 mM dNTPs, 0.5 M each of sense and antisense primers for nt-4, which
yielded a product of 197 bp. A control reaction was done separately with
-actin primers, which yielded a product of 630 bp. The nt-4 PCR was car-
ried out with a sense primer (5-TAC TTC TTC gAg ACg Cg-3) and an
antisense primer (5-AgC TgT gTC gAT CCg AAT CC-3), Wrst at 94 °C
for 3 min, followed by 12 cycles of 94 °C for 20 s, 64 °C for 30 s and 72 °C
for 35 s, followed by 25 cycles of 94 °C for 20 s, 58 °C for 30 s and 72 °C for
3 min. The -actin PCR was performed with a sense primer (5-CTT TTC
ACg gTT ggC CTT Agg gTT-3) and an antisense primer (5-AgA TTA
CTg CCC Tgg CTC CTA g-3) at 94 °C for 4 min, followed by 29 cycles of
94 °C for 30 s, 60 °C for 45 s and 72 °C for 10 min. As a negative control,
Dnase-treated RNA from retina was screened by PCR with nt-4 primers
to conWrm the absence of genomic DNA. This control showed that the
PCR product was ampliWed from cDNA and not from residual genomic
DNA in the retinal samples. The RT-PCR products were visualized by
agarose gel electrophoresis.
2.2. Riboprobe synthesis
Mouse cDNA obtained from the nt-4 RT-PCR was gel excised and
puriWed using the QiaQuick puriWcation system. The cDNA was cloned
into a pCR II-TOPO vector, and sequenced to check for the correct orien-
tation of the insert and identity to the NT-4 gene sequence. The plasmid
(5 g) was linearized with restriction enzymes and puriWed with the Qia-
Quick puriWcation system. Digoxigenen-labeled antisense and sense ribo-
probes were then synthesized using the respective RNA polymerase
(Ambion Inc, Austin, TX) and DIG RNA labeling system (Boeringher,
Germany) according to the manufacturer’s instruction.
2.3. In situ hybridization
High sensitivity non-radioactive in situ hybridization (Pattabiraman
et al., 2005; Tongiorgi, Righi, & Cattaneo, 1998) was performed in adult
WT mice to check for the retinal layers expressing NT-4 mRNA (n D 4
from nt-4+/+ mice and n D 4 from nt-4¡/¡ mice). The retinas were harvested
in the light phase of the diurnal cycle. Retinal sections of 14 m thickness
were serially sectioned on a cryostat and were washed in PBS 0.1% Tween
20 (PBST). The permeabilization consisted of incubation for 5 min in 2.3%
sodium borohydride in 0.1 M Tris–HCl (pH 7.5) followed by 1 mg/ml
Proteinase K (Sigma–Aldrich). The time of incubation with Proteinase K
was standardized for the various animal groups used. After a wash in
PBST, tissue was Wxed for 5 min in 4% paraformaldehyde (PFA).
Thereafter, prehybridization was carried out at 55 °C for 1 h; incubation
with digoxygenin-labeled antisense or sense (control) riboprobe was done
overnight at 58 °C followed by post-incubation washes. Immunodetection
was done with an anti-DIG antibody F(ab) fragment conjugated to alka-
line phosphatase (Roche Biochemicals, Switzerland) at 1:1000 dilution,
which was incubated with the sections overnight at 4 °C. Subsequently the
sections were washed and developed with NBT/BCIP reaction. An unbi-
ased blind development procedure was used; in particular, reaction was
carried out for the same time period for both wild type and the knock out
mice in a blind and parallel manner. The reaction was stopped by a stop
solution (10 mM Tris–HCl pH 8, 1 mM EDTA) after 35 min for both
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gelatin-coated slides, cleared with ethanol and xylene and Wnally mounted
with Eukitt mounting medium.
2.4. Enzyme-linked immunosorbent assay (ELISA) for NT-4 and 
BDNF
Retinas (n D 4 from nt-4+/+ mice and n D 4 from nt-4¡/¡ mice) were
extracted and immediately homogenized in 5 volumes of 100 mM Tris buVer
(pH 7.4) containing 500 mM NaCl, 2% TritonX-100, 1% NP40, 10% glyc-
erol, and protease and phosphatase inhibitors: 1 mM PMSF, 10 g/ml apro-
tinin, 1g/ml leupeptin, 0.5 g/mL antipain, 100g/mL benzamidine, 0.1g/
mL pepstatin A and 0.5 mM sodium vanadate. This homogenate was centri-
fuged at 14,000 rpm for 30 min and the supernatant fraction was used for
ELISA. We performed a sandwich ELISA using the NT-4 and BDNF Emax
immunoassay system from Promega (USA) to measure retinal levels of NT-
4 and BDNF, respectively. BrieXy, 96-well plates were coated with anti-NT4
or anti-BDNF monoclonal antibody and incubated at 4 °C for 18 h. The
plates were incubated in a blocking buVer for 1 h at room temperature, then
samples were added. The samples, NT-4 and BDNF standards were incu-
bated for 2 h, followed by washing with the appropriate buVer. Successively,
the plates were incubated with anti-human NT-4 or anti-human BDNF
polyclonal antibody at room temperature for 2 h, washed, and then incu-
bated with specie speciWc anti-IgG antibody conjugated to horseradish per-
oxidase for 1 h at room temperature. The plates were Wnally incubated with
chromogen substrate to produce color reaction. The reaction was stopped
with 1 M HCl and absorbance was measured at 450 nm using a microplate
reader (Model 550, Bio-Rad Laboratories).
The washes were done at least Wve times in 20 mM Tris–HCl (pH7.6),
150 mM NaCl and 0.05% Tween 20. For each ELISA, the dilutions were
such that the NT-4 and BDNF concentrations were within the manufac-
turer’s recommended range.
2.5. DA and DOPAC analysis
Levels of DA and 3,4-dihydroxyphenylacetic acid (DOPAC) in mouse
retina were determined by a minor modiWcation of the method of Nir,
Haque, and Iuvone (2000). Each retina was homogenized in 70 l of 0.2 N
HClO4 containing 0.01% of sodium metabisulWte and 100 ng/ml of 3,4-
dihydroxybenzylamine hydrobromide, an internal standard. After centrifu-
gation at 15,000g for 10 min, a 20l aliquot of supernatant was analyzed for
DA and DOPAC by ion-pair reverse-phase high performance liquid chro-
matography with amperometric detection (glassy carbon working electrode
at 0.65 V vs AgCl reference electrode). The separation was performed on an
Ultrasphere ODS 250 £ 4.6 mm column, 5 m (Beckman Coulter, USA)
with a mobile phase containing 0.1 M sodium phosphate, 0.1 Mm EDTA,
0.35 Mm sodium octyl sulfate, 5.5% acetonitrile (vol/vol), pH 2.7. External
standards of DA and DOPAC were analyzed in each experiment. DA and
DOPAC levels were normalized to retinal protein (Lowry, Rosebrough,
Farr, & Randall, 1951), using bovine serum albumin as standard.
The levels of dopamine, DOPAC and the ratio DOPAC/dopamine were
measured in two groups of adult nt-4+/+ and two groups of adult nt-4¡/¡
mice; in one group, retinas were dissected 1 h after the onset of light in the
morning (ZT1) (n D 3 from nt-4+/+ mice and n D 3 from nt-4¡/¡ mice); in the
second group, retinas were dissected at ZT23, 1 h before light onset at the
end of the night (n D 3 from nt-4+/+ mice and n D 3 from nt-4¡/¡ mice). ZT23
retinas were dissected under dim red light. DiVerences between data from nt-
4¡/¡ and control mice at ZT1 and ZT23 were evaluated by two way analysis
of variance (ANOVA); pairwise comparisons between groups were made
using the Student–Newman–Keuls multiple comparison test.
2.6. Histology
Adult and P15 mice, previously anesthetized with an intraperitoneal
injection of avertin, were perfused transcardially with 4% paraformalde-
hyde (PFA) in 0.01 M phosphate buVer, pH 7.4 (PB) in the light phase dur-
ing the diurnal cycle. The eyes were enucleated, the anterior chamber wasremoved and the eyecups were Wxed for 30 min in the same solution. The
Wxed eye cups were washed in PB several times and then cryoprotected in
30% sucrose in PB at 4 °C overnight. Eye cups were then embedded in
cryomatrix (Tissuetek, Reichart-Jung, Nuloch, Germany) and frozen.
Radial sections (14 m) were cut on a cryostat (Reichart-Jung, Nuloch,
Germany), collected onto gelatin-coated slides, air-dried, and stored at
¡20 °C until further processing. Propidium iodide (Molecular Probes,
1:1000 in PBS), a nuclear stain Xuorescent in the red spectra, was used to
compare the number of rows of photoreceptors in the retina of control
and mutant mice.
2.7. Immunocytochemistry
Six nt-4+/+ and six nt-4¡/¡ adult mice and six nt-4+/+ and six nt-4¡/¡ P15
mice were used to perform immunocytochemistry on cryosections. Retinal
cross-sections were washed three times in PB and then incubated for 2 h at
room temperature in a solution containing 5% bovine albumin (BSA), and
0.3% Triton X-100 in 0.01 M phosphate-buVer at pH 7.4 (PB) (Sigma–Ald-
rich, St. Louis, MO). Primary and secondary antibodies were diluted in a
solution containing 1% BSA and 0.1% Triton X-100 in PB; primary anti-
bodies were applied overnight at 4 °C.
The following primary antibodies were used at the indicated dilutions,
determined either from the referenced protocols or from the results of a
dilution series: polyclonal anti-protein kinase C (PKC-alpha, Santa Cruz
Biotechnology, Inc., Santa Cruz, CA; 1:1000 after run dilution series), a
marker for rod-bipolar cells; monoclonal anti-calbindin-D28K (Sigma–
Aldrich, St. Louis, MO; 1:1000; Pignatelli, Cepko, & Strettoi, 2004), a
marker for horizontal cells; polyclonal anti-disabled-1, a marker for AII
amacrine cells (DB-1, a kind gift of D. Rice, Memphis, USA; 1:1000 after
run dilution series); polyclonal anti-tyrosine hydroxylase (TH, Chemicon,
Temecula, CA; 1:500 after run dilution series), a marker for dopaminergic
amacrine cells (Witkovsky et al., 2004); polyclonal anti-parvalbumin
(Swant, Switzerland; 1:1000; Pignatelli & Strettoi, 2004), a marker for
mouse retinal ganglion cells (Kim & Jeon, 2006).
Secondary antibodies, conjugated to Alexa 488 (Molecular Probes,
Eugene, OR; 1:400), were applied for 2 h at room temperature. Sections
were washed three times in PB and then coverslipped with Vectashield
(Vector laboratories, Burlingame, CA). To control for the speciWcity of the
antibodies, parallel experiments with omitted primary antibody were per-
formed in control and mutant mice.
For whole mount immunostaining experiments, retinas were separated
from the pigment epithelium and four radial cuts were made to allow them to
Xatten. The retinas were then post Wxed in 4% paraformaldehyde for 30 min.
Samples were rinsed in 0.01M phosphate buVer at pH 7.4 (PB) for 15 min
and put in blocking solution (5% BSA, 0,3% Triton X-100 in PB) overnight at
4 °C. Retinas were incubated with antibody solution (polyclonal anti-tyrosine
hydroxylase TH, Chemicon, 1:200, 1% BSA, 0,1% Triton X-100 in PB) and
left at 4 °C for Wve days, washed several times in PB, and placed for 2–3 days
in the secondary antibody solution (anti-rabbit Alexa 488, 1% BSA, 0,1% Tri-
ton X-100 in PB) to reveal immunoreactive cells.
2.8. QuantiWcation of TH immunopositive cell bodies and 
varicosities in whole mount retina
Counts of TH immunopositive cell bodies and varicosities were made
from whole mount retina of nt-4+/+ (n D 4) and nt-4¡/¡ (n D 4) mice using a
Xuorescence Nikon microscope with a Plan-Four 4£/0.13 objective. Each
retina was subdivided randomly in four quadrants. We acquired and
printed one image for each retinal quadrant from which the entire retinal
surface was reconstructed. Each dopaminergic cell was counted from the
prints. The size of the whole retina was measured with Metamorph® soft-
ware in adult mutant (n D 4) and control mice (n D 4) after acquisition of
four retinal quadrants with the Xuorescence microscope.
For quantiWcation of TH immunopositive varicosities, each retinal
quadrant was further subdivided in 3 Welds of acquisition: one peripheral,
one mid-peripheral and one central (5/6, 3/6 and 1/6 of retinal radius). For
each Weld, serial optical sections were acquired using a Leica TCS-NT con-
focal microscope equipped with a krypton-argon laser and high resolution
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1.0 objective. The optical sections were 1 m apart and they covered the
total thickness of the TH immunopositive network, localized in the inner
plexiform layer (IPL). Given an optical z-resolution of »0.7 m, and the
fact that almost no varicosities are conWned to a single z-plane, this spac-
ing was selected to minimize chances of over-sampling or undersampling.
In whole mount retina, the TH immunopositive processes contained
two classes of varicosities: one class is organized into pericellular rings
surrounding the somas of AII amacrine cells (Kolb, Cuenca, Wang, &
Dekorver, 1990), and another class containing all the varicosities not con-
tacting the cell bodies of these amacrine cells (non-AII varicosities). The
numbers of these two types of dopaminergic varicosities were quantiWed
by dividing each 252 £ 252 m image, representing a single optical section
in a Z-stack, into 144 squares of 21 £ 21 m. By using a random number
table, we selected the squares to be analysed, and counted the number of
varicosities forming each of six diVerent rings, expressing the Wnal count as
the mean number of varicosities/ring averaged over a total of 288 ran-
domly selected rings in 48 diVerent optical sections from four diVerent
mice for each genotype. We also counted the number of rings in six diVer-
ent frames using the same sampling method. A sample size of six provides
suYcient statistical power to accurately determine the average number of
varicosities per ring and assess whether there is a statistically signiWcant
diVerence between WT and KO mice in this parameter.
Finally, in two diVerent frames randomly sampled we counted the
number of non-AII varicosities (see Fig. 5B and C). DiVerences between
the data obtained in nt-4+/+ and nt-4¡/¡ mice were tested statistically with
the Student’s t test.
2.9. QuantiWcation of TH stained areas in cross-sections of retina
The retinal TH stained areas in the IPL and in the outer plexiform
layer (OPL) of nt-4¡/¡ P15 mice (n D 6), nt-4+/+ P15 mice (n D 6), nt-4¡/¡
adult mice (n D 6), and nt-4+/+ adult mice (n D 6) were quantiWed using
Metamorph® software (Universal Imaging Corp.). TH stained retinal sec-
tions were acquired using a confocal microscope. For each animal, 3 Z-
stack of serial images were acquired and for each of these, an area of Wxed
size was selected within the OPL and the IPL. The number of pixels above
a Wxed threshold of brightness was calculated within the selected areas.
The threshold of brightness, the same for every Z-stack of serial imagesanalyzed, was chosen to eliminate the nonspeciWc background signal in
immunostained TH retinal sections; to this aim, at Wrst we evaluated the
mean variation in background for each mouse and then we utilized a
threshold well over the mean noise level. Since the distribution of pixels
over threshold was non-Gaussian, we used the Wilkoxon–Mann Whitney
U-test (Statistica, Statsoft) to test for statistical diVerences. QuantiWcation
of TH immunostained processes in the retina of nt-4+/+ and nt-4¡/¡ mice
was performed blind.
3. Results
3.1. NT-4 is expressed in the adult and P15 retina of wild 
type mouse
We carried out RT-PCR experiments on retinal RNA
obtained from nt-4+/+ adult and P15 mice with primers
designed from the coding region of the nt-4 gene. A speciWc
band of approximately 200 bp was ampliWed (Fig. 1) in
adult and P15 WT mice while it was absent in nt-4¡/¡ adult
and P15 mice. To control for genomic DNA contamina-
tion, nt-4 PCR was performed on retinal RNA not treated
with reverse transcriptase; no PCR product was detected in
these samples (-RT in Fig. 1A). In addition, we detected
expression of NT-4 protein in the retina of wild type mice
using enzyme-linked immunosorbent assay (ELISA, see
Section 2 and previous report by Fan et al., 2000). NT-4
was found to be expressed without signiWcant changes of
the protein level between P15 and adult retinas. No signal
was detected in homogenates from nt-4¡/¡ mice retinas
(Fig. 1C).
To localise retinal cells expressing NT-4 mRNA, we per-
formed non-radioactive in situ hybridization (Pattabiraman
et al., 2005; Tongiorgi et al., 1998) on retinal cross-sections
of nt-4+/+ and nt-4¡/¡ adult mice. Positive staining wasFig. 1. NT-4 RT-PCR in the retina from adult and P15 wild type mice. (A) A band of about 200 bp, corresponding to a partial NT-4 transcript, was ampli-
Wed from retinal RNA of nt-4+/+ P15 and adult mice (WT); the amplicon was absent in nt-4¡/¡ samples (KO). To control for genomic DNA contamina-
tion, PCR was performed on retinal RNA not treated with reverse transcriptase (see -RT lanes, nt-4 P15 and nt-4 AD). AD means adult. (B) Positive
control RT- PCR for -actin mRNA. (C) NT-4 protein level (pg/mg tissue) was determined by ELISA. NT-4 was detected in retina of nt-4+/+ but not
nt-4¡/¡ mice. The diVerence between P15 and adult level of NT-4 in WT mice (P15 WT and A WT, respectively) was not statistically signiWcant.
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to the cells of the inner nuclear layer (INL), to the outer
nuclear layer (ONL) and in a few cells of the ganglion cell
layer (GCL). Although the level of hybridization is clearly
lower in the ONL than in the INL, the reaction product in
these two retinal layers appears to be distributed in rings
that outline the soma or nucleus. The only solidly labeled
cells are in the retinal ganglion cell layer. In particular, the
Fig. 2. In situ hybridization on retinal cross-sections of nt-4+/+ and nt-4¡/¡
mice. (Top row) In the retina of adult nt-4+/+ mice, the staining was local-
ized in cells of the ONL, INL and GCL (see arrowheads). (Bottom row).
The retinal cross-sections of adult nt-4¡/¡ mice showed diVuse, non-spe-
ciWc staining throughout all retinal layers. Abbreviations: ONL, outer
nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL,
inner plexiform layer; GCL, ganglion cell layer. Scale bars are reported
between top and bottom row.hybridization signal in the most inner part of INL of wild
type mice localized to a spatial position typical for ama-
crine cells. The retinal sections of nt-4¡/¡ mice lacked local-
ised staining in any retinal layer (Fig. 2).
Further control for speciWcity was performed using a
sense riboprobe on wild type retinas; in this experimental
condition no signal was detected (data not shown). Thus,
the nt-4 gene is actively transcribed in retina, mainly in cells
in the INL and GCL.
3.2. Tyrosine hydroxylase immunocytochemical analysis of 
the retina of nt-4¡/¡ mice
We performed immunocytochemistry on cross-sections
of nt-4+/+ and nt-4¡/¡ mouse retina using an antibody rec-
ognizing tyrosine hydroxylase (TH), the rate limiting
enzyme for dopamine synthesis. The somata of TH immu-
nostained amacrine cells are found in the innermost part of
the INL (Fig. 3) and a network of TH-immunoreactive pro-
cesses is localized in stratum 1 (S1) of IPL, in accordance
with previous data on the retinal dopaminergic network
(Cellerino et al., 1998; Dacey, 1990; Voigt & Wassle, 1987;
for a review see Witkovsky, 2004). In addition, this retinal
cell expresses TrkB (Cellerino & Kohler, 1997) and, thus, is
potentially sensitive to NT-4. TH immunocytochemistry on
retinal cross-sections of nt-4¡/¡ adult mice revealed diVer-
ences with respect to nt-4+/+ mice. Some of these TH immu-
nopositive cells extend ascending processes towards the
OPL. In nt-4¡/¡ adult mouse, these ascending processes
appeared more widespread than in nt-4+/+ mice, occupying
a greater retinal area, particularly in the OPL (Fig. 3, see A
and B, see also quantitative results in Fig. 4).
At P15, TH immunopositive retinal cells are not yet fully
mature (Wulle & Schnitzer, 1989) and, therefore, this
postnatal age represents a developmental stage of activeFig. 3. TH immunocytochemistry in nt-4+/+ and nt-4¡/¡ adult and P15 retinal sections. Immunocytochemistry in radial sections of retinas with TH anti-
body identiWes not only the dopaminergic network that is localized at the border between INL and IPL, but also the processes that ascend towards the
OPL. Adult retinas are illustrated in (A) and (B); P15 retinas are shown in (C) and (D). The TH-immunopositive cell bodies are not shown in the images.
The spread of dopaminergic ascending processes in retinal sections of nt-4¡/¡ (B) was increased compared to that in control retinal sections of nt-4+/+ adult
¡/¡ +/+mice (A). Similarly, the spread of the ascending processes was greater in retinas of nt-4  mice (D) than in those of nt-4  mice (C) at P15. Also, the dopa-
minergic plexus in the IPL of P15 nt-4¡/ ¡ mice (D) was increased with respect to that in age-matched nt-4+/+ mice (C). Scale bar (20 m) is reported in (D).
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particularly true of dopaminergic processes, whose growth
during the 3rd postnatal week was documented by Witkov-
sky, Arango-Gonzalez, Haycock, and Kohler (2005). TH
immunocytochemistry performed on retinal sections of P15
nt-4+/+ and nt-4¡/¡ mice revealed a distribution of ascend-
ing dopaminergic processes in nt-4¡/¡ mice, similar to what
is observed in adult mice. In addition, P15 nt-4¡/¡ mice
showed an increase in the thickness of dopaminergic net-
work localised in the IPL (Fig. 3, compare C, D). Thus, the
absence of NT-4 aVects the maturation of the dopaminergic
phenotype in the mouse retina.
The areas occupied by dopaminergic Wbers in the OPL
and IPL were quantiWed by counting pixels over a Wxedthreshold of brightness within windows of standardized
size (see Section 2). The distribution of pixel number over
threshold in the OPL and in the IPL of nt-4+/+ and nt-4¡/¡
adult and P15 mice is illustrated in Fig. 4. In adult mice, sig-
niWcant diVerences between nt-4+/+ (n D 6) and nt-4¡/¡
(n D 6) genotypes were found in the OPL only; in mutant
mice, the area of the OPL occupied by dopaminergic Wbers
was 2.5 times that of nt-4+/+ (U-test, p D 0.003). Analysis of
P15 mouse retinas revealed a 281% increase in the OPL in
nt-4¡/¡ (n D 6) compared to nt-4+/+ (n D 6) mice (U-test,
p D 0.004). In addition, the area occupied by the dopaminer-
gic processes in the IPL of P15 nt-4¡/¡ mice was 1.2 times
higher than that of age-matched nt-4+/+ controls (U-test,
p D 0.05).Fig. 4. QuantiWcation of TH process spread in retinas of nt-4¡/¡ and nt-4+/+ mice. The image in (A) shows mouse retinal section acquired using a confocal
microscope with low, non saturating intensity; the image in (B) shows the same retinal section as in (A), following the application of a brightness
threshold. For each image, two areas of Wxed size were selected in the OPL and IPL. The white pixels within rectangles and over Wxed threshold were
counted using Metamorph® software. The distributions of pixels over threshold in the OPL and in the IPL of nt-4+/+ (WT) and nt-4¡/¡(KO) mice in adult-
hood and at P15, are presented in the histograms. Quantitative analysis of TH immunoreactivity performed in the IPL of adult mice (adult retina) did not
reveal signiWcant diVerences between nt-4+/+ and nt-4¡/¡ mice; in contrast, a signiWcant increase in the area occupied by dopaminergic ascending Wbers was
present in the OPL of nt-4¡/¡ adult mice (U-test, p D 0.003). In P15 retina of nt-4¡/¡ mice, the morphometric analysis of TH immunoreactivity revealed a
74% increase in the area occupied by dopaminergic network in the IPL (U-test, p D 0.05) and a 281% increase in the area occupied by dopaminergic
ascending Wbers in the OPL (U-test, p D 0.004) compared to nt-4+/+ mice. In the graphics the dots represent median values, the boxes represent the 25–75%
percentile intervals and the bars represent minimum and maximum values. The analysis was performed on nt-4¡/¡ (n D 6) and nt-4+/+ (n D 6) at P15, and
on nt-4¡/¡ (n D 6) and nt-4+/+ (n D 6) adult mice.
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were apparently unaVected in adult IPL of mutant mice
prompted us to investigate the dopaminergic circuitry of
the IPL in more detail. We examined the varicosities dis-
tributed along the TH immunopositive processes. DiVerent
types of TH varicosities have been previously described in
dopaminergic cells (Kolb et al., 1990). One type organizes
into pericellular rings (Tork & Stone, 1979) surrounding
the cell bodies of AII amacrine cells. Also A17 amacrine
cells may present dopaminergic varicosities around their
soma that often appear as half ring; both types of varicosi-
ties belong to the rod pathway (BloomWeld & Dacheux,
2001; Famiglietti & Kolb, 1975; Voigt & Wassle, 1987).
Another type includes all the varicosities not contacting
somas of AII and other amacrine cells (non-AII varicosi-ties). In analysed mouse retinas, we found dopaminergic
non-AII varicosities and dopaminergic varicosities forming
pericellular rings, thus likely to be on AII amacrine cells
(Fig. 5A). Non-AII TH immunopositive varicosities
showed a 20% increase in nt-4¡/¡ retina (MeanD 53,
SD D 2,9, n D 4) relative to nt-4+/+ (Mean D 44,5, SD D 4,8,
n D 4) retina (Fig. 5B, t-test, p < 0.01). This result was spe-
ciWc, since neither the varicosities forming a typical ring
around the cell bodies of AII amacrine cells nor the number
of rings was diVerent between genotypes (Fig. 5C). In addi-
tion we found that the number of TH stained cell bodies
was not signiWcantly diVerent between nt-4¡/¡ (Mean D 611,
SD D 76, n D 4) and nt-4+/+ mice (Mean D 588, SD D 115,
n D 4) (Fig. 6C). To exclude non speciWc eVects due to
changes of retinal size, we measured the total area in wholeFig. 5. Non-AII varicosities are aVected in the retina of nt-4¡/¡ mice. (A) Illustration of the method used to count the TH immunopositive varicosities in
whole mount retina. One retinal Weld was acquired using a confocal microscope. The number of two types of TH immunostained varicosities (pericellular
rings and non-AII varicosities) present in the image was measured superimposing a grid made of 21 £ 21 m frames (12 £ 12 matrix). These varicosities
were counted in quadrants randomly sampled (see Section 2). Each varicosity was marked after counting to avoid recounting. Higher magniWcations of
two frames in the left and right bottom corner represent pericellular rings (left side) and non-AII varicosities, (right side), respectively, after counting and
marking. (B) Histogram. The number of TH immunostained non-AII varicosities showed a 20% increase in nt-4¡/¡ over those present in nt-4+/+ retina (*,
t-test, p < 0.01). The analysis was performed on mutant (n D 4) and control mice (n D 4). Columns represent the means (SD is represented as vertical bar).
(C) Histogram. On the left side, the mean density of TH rings and on the right side, the mean number of TH varicosities per ring are shown. There is no
diVerence between control (n D 4) and mutant (n D 4) mice. Columns represent the means (SD is represented as vertical bar).
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ences between mutant and control mice (Fig. 6B). These
results indicate that in  nt-4¡/¡ mice there is an increase in
dopaminergic varicosities that is speciWcally directed to
non-AII targets.
In order to determine whether an increased spread of
TH immunopositive processes and a high number of TH
varicosities is associated with a change of dopamine synthe-
sis and/or turnover, we measured the steady-state levels of
DA and its metabolite DOPAC during the night (1 h before
lights on, ZT23) and in light, 1 h into the day (ZT1). There
were no signiWcant diVerences in steady state DA level
between nt-4+/+ and nt-4¡/¡ mice (Fig. 7A). To ascertain
whether dopamine turnover was altered in the absence of
NT-4, the ratio DOPAC/DA was calculated. In agreement
with previous reports (e.g. Nir et al., 2000), the DOPAC/
DA ratio increased 1 h after light onset in the morning in
both mutant and control mice (Student–Newman–Keulstest p < 0.01; Fig. 7C). No signiWcant diVerences in the
DOPAC/DA ratio were found between nt-4+/+ and nt-4¡/¡
mice in darkness. However, the DOPAC/DA ratio 1 h after
light onset was »30% higher in nt-4¡/¡ mice compared with
nt-4+/+ controls (Student–Newman–Keuls test p < 0.01;
Fig. 7C). Thus, a higher level of light-evoked DA turnover
in retinae of nt-4¡/¡ mice correlates with the larger number
of non-AII TH positive varicosities and the increased
spread of dopaminergic Wbers.
We next examined whether the altered retinal TH immu-
nopositive neurons in mutant mice were associated with
changes of BDNF protein, the other member of neurotrophin
family that binds to TrkB. Examination of BDNF by ELISA
revealed a normal level in the retina of mutant mice (nt-4+/+
mice, nD4, 67§41 pg/mg protein; nt-4¡/¡ mice, nD4, 67§21
pg/mg protein, data not shown). These data indicate that
alteration of TH immunopositive retinal cells in nt4¡/¡ mice is
not due to a compensatory up-regulation of BDNF level.Fig. 6. The number of TH immunopositive cell bodies is unchanged in the retina of nt-4¡/¡ mice. (A) Dopaminergic cell bodies were stained in whole
mount retina of nt-4+/+ (n D 4) and nt-4¡/¡ (n D 4) mice; we illustrate an example of retina stained with TH antibody. Scale bar D 250 m. (B) The analysis
of retinal size performed on the retina of four nt-4+/+ and four nt-4¡/¡ revealed no statistically signiWcant diVerence. Columns represent the means (SD is
represented as vertical bar). (C) Histogram. The number of TH stained cell bodies was not signiWcantly diVerent between nt-4¡/¡ (Mean D 611, SD D 76)
and nt-4+/+ (Mean D 588, SD D 115).
M. Calamusa et al. / Vision Research 47 (2007) 1523–1536 1531Finally, we analysed the eVects induced by NT-4 deple-
tion on other retinal cell subtypes in order to exclude gross
impairment of retinal circuitry. To this aim we used the fol-
lowing speciWc markers of retinal cells: protein kinase C
(marker for rod bipolar cells), calbindin (marker for hori-
zontal cells), disabled-1 (marker for AII amacrine cells),
and parvalbumin (marker for mouse ganglion cells, Kim &
Jeon, 2006). In addition, we examined photoreceptors using
propidium iodide as a marker. Lack of nt-4 gene did not
grossly aVect the maturation of photoreceptors, rod bipo-
lar, horizontal, AII amacrine and ganglion cells, as illus-
trated in Fig. 8.
4. Discussion
In the present paper, we report that both NT-4 mRNA
and protein are expressed in the wild type mouse retina.
NT-4 absence in NT-4 knockout mice is associated with an
abnormal maturation of TH immunostained retinal cells.
We showed the presence of NT-4 mRNA using RT-PCR
and in situ hybridization. NT-4 mRNA is expressed in sev-
eral cells of diVerent retinal layers but it is most concen-
trated in the INL and, particularly, in cells that have the
location of amacrine cells. This result suggests that expres-
sion of NT-4 mRNA is particularly relevant in the inner
retina and supports a possible direct action of NT-4 on
amacrine cells. Concerning the NT-4 protein measurement,
although this measurement is diYcult to interpret due to
protein traYcking between the retina and its targets (for a
review see Frost, 2001), our data indicate that NT-4 protein
is expressed at low level both during postnatal development
(P15) and in adult mouse retina.
To investigate whether NT-4 deprivation aVects matura-
tion of retinal circuitry in the mouse retina, we analysed the
phenotype of retinal cells in null mutant mice devoid of nt-4
gene. Nt-4¡/¡ mice are the only strain of neurotrophin
knock out whose homozygous mutants are viable. Detailed
analysis of these mice revealed restricted and peripheralalterations at both anatomical and functional levels
(Conover et al., 1995; Erickson et al., 1996; Fox et al., 2001;
Liu et al., 1995; Lucas et al., 2003; Roosen et al., 2001;
Smith et al., 2003; Stucky et al., 2002; Xie et al., 2000).
Our results showed that the absence of NT-4 targets TH
immunopositive cells, while several other retinal neurons
do not appear to be grossly aVected. Lack of NT-4 causes
a general alteration of these cells, as shown using immunocyto-
chemistry for TH. In particular, our results revealed an
increase of the retinal area occupied by the TH immuno-
positive network, which in P15 mice involves ascending
dopaminergic processes in OPL and the dopaminergic
plexus localized in IPL, whereas in adult the alterations are
restricted to the OPL.
Dopamine is the primary catecholamine neurotransmit-
ter synthesized in the retina of most vertebrate species (Iuv-
one, 1986), and the TH immunopositive amacrine cells are
generally considered to be dopaminergic (Witkovsky et al.,
2004). The morphology of these cells in mammalian retina
is well-described (for a review see Witkovsky, 2004) and at
least diVerent sites of dopamine release can be clearly diVer-
entiated: varicosities organized into pericellular rings,
which speciWcally target AII amacrine cells (BloomWeld &
Dacheux, 2001; Kolb et al., 1990) and varicosities not con-
tacting these particular neurons. As only the latter is
aVected in nt-4¡/¡ mice we conclude that absence of NT-4
speciWcally aVects a deWned subset of varicosities not asso-
ciated with the rings. It must be noted that even if these var-
icosities are not adjacent to a particular cell type, the
dopamine released there may ultimately aVect them by
diVusion (for review see Witkovsky et al., 2004). DiVusion
distances of dopamine can be small—less than 1m—or
very great—tens of microns, in this way aVecting many reti-
nal cells expressing dopamine receptors.
The greater spread of TH immunopositive processes
and higher number of varicosities in retinas of nt-4¡/¡ mice
was expected to aVect DA content and metabolism. We
investigated diurnal variations in the levels of DA and itsFig. 7. Dopamine and DOPAC levels in the retina of nt-4+/+ and nt-4¡/¡ mice. The steady-state levels and turnover of DA were evaluated in two groups of
adult nt-4+/+ and two groups of adult nt-4¡/¡ mice; one group was dissected 1 h after light onset (ZT1) and the other dissected 1 h before light onset
(ZT23). For each group, 6 pairs of retinas were used at ZT1 and 6 pairs at ZT23. Levels of DA and DOPAC, the main DA metabolite, in mouse retina
were determined by high-pressure liquid chromatography (HPLC). (A) There are no signiWcant eVects of genotype or light exposure on DA levels. (B)
Light exposure signiWcantly increased DOPAC levels (p < 0.001) with no signiWcant eVect of genotype. (C) The DOPAC/DA ratio, an index of DA turn-
over, was signiWcantly increased by light exposure in both genotypes (p < 0.001); there was a signiWcant eVect of genotype (p < 0.05) and a signiWcant inter-
action of lighting condition and genotype (p < 0.05). The DOPAC/DA ratio was higher in nt-4¡/¡ mice compared to nt-4+/+ mice at ZT1 in light
(**p < 0.01), but not in darkness at ZT23 (p D 0.883).
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We observed a normal content of DA in the retina of nt-4¡/¡
mice with an increased turnover of DA, as assessed by mea-
suring the DOPAC/DA ratio. However, whether altered
DA turnover stems from a diVerent rate of release at the
rings around AII or at non-AII varicosities remains to beinvestigated. Previous reports (e.g., Iuvone, Galli, Garrison-
Gund, & NeV, 1978; Nir et al., 2000) and the present data
showed that light stimulates the turnover of DA in the retina
without signiWcantly aVecting the steady state level of the
transmitter. Interestingly, diVerences of DA turnover between
nt-4¡/¡ and nt-4+/+ mice were observed only followingFig. 8. Immunocytochemistry on retinal sections. Confocal Xuorescence photomicrographs of radial sections through mouse retinas that were labelled
using diVerent cellular markers. The propidium iodide staining, used to assess the rows of photoreceptor nuclei (A and B), and immunocytochemistry for
protein kinase C (C and D), a marker for rod bipolar cells, calbindin (E and F), a marker for horizontal cells, disabled-1 (G and H), a marker for AII
amacrine cells, and a parvalbumin (I and L) marker for retinal ganglion cells, did not reveal diVerences between nt-4+/+ and nt-4¡/¡ mice. Scale
bar D 20 m.
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aVect the amount of basal, unstimulated DA release and/or
metabolism. We hypothesize that the increased TH immu-
nopositive processes and varicosities associated with the
absence of NT-4 release proportionately higher amounts of
DA upon stimulation with light, and that the DA released
under these conditions is rapidly metabolized to DOPAC.
Thus, deletion of NT-4 induces an alteration of the retinal
dopaminergic network with associated changes of stimu-
lated DA turnover in light.
4.1. What is the functional impact of the present data?
The result showing that NT-4 has a role in modulating
the complexity of TH immunopositive retinal processes is
in line with a large body of experimental evidence show-
ing that neurotrophins control the maturation of neuro-
nal processes in cortical areas and in hippocampus (Croll
et al., 1999; Horch, Kruttgen, Portbury, & Katz, 1999;
McAllister, Lo, & Katz, 1995; McAllister, Katz, & Lo,
1996; McAllister, Katz, & Lo, 1997; Tolwani et al., 2002;
Wirth, Brun, Grabert, Patz, & Wahle, 2003). SpeciWcally
in the retina, NT-4 exerts an opposite action to that of
BDNF on the TH immunopositive network. Indeed, an
exogenous supply of BDNF in developing retina induces
an increase of the dopaminergic network (Cellerino et al.,
1998) similar to the results found in nt-4¡/¡ mice. In par-
ticular, intraocular injections of BDNF during postnatal
development cause increased TH expression and the den-
sity of TH immunopositive varicosities in rat retina. On
the other hand, in mice homozygous for a null mutation
of the bdnf gene, retinal dopaminergic neurons are atro-
phic and the density of TH positive varicosities is reduced
(Cellerino et al., 1998). The possibility that changes in the
nt-4¡/¡ mice are due to a compensatory up-regulation of
BDNF can be excluded since we showed that the BDNF
protein level is unchanged.
Opposite actions of diVerent neurotrophins on the same
neuronal class have previously been reported. In the devel-
oping cortex, BDNF stimulates and NT-3 inhibits the den-
dritic growth of layer IV pyramidal cells while having the
opposite eVect on dendritic growth of neurons in layer VI
(McAllister et al., 1997). Moreover, the two TrkB receptor
ligands, BDNF and NT-4 exert diVerent actions on the
development of speciWc cortical neurons. Indeed, these two
neurotrophins inXuence the dendritic growth of developing
visual cortical neurons, but with diVerent laminar speciWc-
ity (McAllister et al., 1995). In the developing retina, neurite
outgrowth of ganglion cells is diVerentially modulated by
BDNF and NT-4 (Bosco & Linden, 1999). In this regard
there is increasing evidence for interactive developmental
eVects between amacrine cells and RGCs and we cannot
exclude the possibility that the eVects observed on the TH
immunopositive amacrine cells in nt-4¡/¡ mice are mediated
indirectly via some type of cell-cell interaction.
The novelty of our Wnding is that BDNF and NT-4
can exert opposite actions on a deWned neuronalpopulation. It is now well-known that binding of BDNF
and NT-4 to TrkB activate diVerent intracellular signal-
ling pathways (Minichiello et al., 1998) and that a diver-
gence in TrkB signalling underlies the distinct activities
of NT-4 and BDNF (Fan et al., 2000). In particular the
mutation of the Shc binding site in the trkB gene revealed
distinctive responses to BDNF and NT-4 (Minichiello
et al., 1998). The trkB mutation resulted in selective loss
of NT-4-sensitive sensory neurons with only a modest
eVect on BDNF-sensitive neurons. This result and other
diVerential responses to NT-4 and BDNF in the trkB
mutants suggest a diVerential activation of trkB and its
associated signalling mechanisms by the two ligands
(Minichiello et al., 1998). We extend these previous Wnd-
ings by demonstrating that the divergence of BDNF and
NT-4 signalling can lead to antagonistic biological
actions, at least in the retina.
The biological signiWcance of having BDNF and NT-4
acting on the same TrkB receptor expressed in dopami-
nergic amacrine cells is unclear. TrkB expression in dopa-
minergic cells is a conserved trait of vertebrates (Cellerino
& Kohler, 1997). On the other hand, the morphology of
dopaminergic plexus is highly variable. Dopaminergic
cells form a dense network with processes that stratify in
stratum 1 of IPL, but also accessory innervations in stra-
tum 3 and stratum 5, which are variable even within mam-
mals. Even more variable is the extent of axon-like
processes ascending towards the outer OPL (Dacey, 1990;
Kolb et al., 1990; Kolb, 1997; Voigt & Wassle, 1987). The
present and previous (Cellerino et al., 1998) results
showed that the absence of single genes, the nt-4 and bdnf,
respectively, induce opposite changes in the morphology
of dopaminergic amacrine cells and also inXuence the
extent of the ascending processes. We raise the hypothesis
that the diVerent levels of expression and opposite actions
of BDNF and NT-4 contribute to control the develop-
ment of structural properties of dopaminergic retinal cells
to determine the speciWc architecture of the diVerent
mammalian species.
5. Conclusions
In the present paper we showed that the maturation of
dopaminergic retinal circuitry and dopamine turnover dur-
ing daylight are altered in nt-4¡/¡ mice. We suggest that
NT-4 controls the maturation of dopaminergic processes
and instructs the formation of sites for dopamine release,
possibly including the spatial dynamics of varicosity forma-
tion and their distribution along processes.
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